{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:29:31Z","timestamp":1773772171733,"version":"3.50.1"},"reference-count":65,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT)","award":["UI\/BD\/151318\/2021"],"award-info":[{"award-number":["UI\/BD\/151318\/2021"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT)","award":["SFRH\/BPD\/110001\/2015"],"award-info":[{"award-number":["SFRH\/BPD\/110001\/2015"]}]},{"name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia (FCT)","award":["SFRH\/BD\/129359\/2017"],"award-info":[{"award-number":["SFRH\/BD\/129359\/2017"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Long-term cognitive dysfunction, or \u201cchemobrain\u201d, has been observed in cancer patients treated with chemotherapy. Mitoxantrone (MTX) is a topoisomerase II inhibitor that binds and intercalates with DNA, being used in the treatment of several cancers and multiple sclerosis. Although MTX can induce chemobrain, its neurotoxic mechanisms are poorly studied. This work aimed to identify the adverse outcome pathways (AOPs) activated in the brain upon the use of a clinically relevant cumulative dose of MTX. Three-month-old male CD-1 mice were given a biweekly intraperitoneal administration of MTX over the course of three weeks until reaching a total cumulative dose of 6 mg\/kg. Controls were given sterile saline in the same schedule. Two weeks after the last administration, the mice were euthanized and their brains removed. The left brain hemisphere was used for targeted profiling of the metabolism of glutathione and the right hemisphere for an untargeted metabolomics approach. The obtained results revealed that MTX treatment reduced the availability of cysteine (Cys), cysteinylglycine (CysGly), and reduced glutathione (GSH) suggesting that MTX disrupts glutathione metabolism. The untargeted approach revealed metabolic circuits of phosphatidylethanolamine, catecholamines, unsaturated fatty acids biosynthesis, and glycerolipids as relevant players in AOPs of MTX in our in vivo model. As far as we know, our study was the first to perform such a broad profiling study on pathways that could put patients given MTX at risk of cognitive deficits.<\/jats:p>","DOI":"10.3390\/ijms241713126","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T08:57:39Z","timestamp":1692781059000},"page":"13126","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Clinically Relevant Dosage of Mitoxantrone Disrupts the Glutathione and Lipid Metabolic Pathways of the CD-1 Mice Brain: A Metabolomics Study"],"prefix":"10.3390","volume":"24","author":[{"given":"Ana","family":"Dias-Carvalho","sequence":"first","affiliation":[{"name":"Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"},{"name":"UCIBIO\u2014Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4073-2121","authenticated-orcid":false,"given":"Ana","family":"Margarida-Ara\u00fajo","sequence":"additional","affiliation":[{"name":"Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"},{"name":"UCIBIO\u2014Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2775-3147","authenticated-orcid":false,"given":"Ana","family":"Reis-Mendes","sequence":"additional","affiliation":[{"name":"Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"},{"name":"UCIBIO\u2014Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]},{"given":"Catarina Oliveira","family":"Sequeira","sequence":"additional","affiliation":[{"name":"iNOVA4Health, LS4Future, NOVA Medical School|Faculdade de Ci\u00eancias M\u00e9dicas (NMS|FCM), Universidade Nova de Lisboa, 1150-082 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8456-9995","authenticated-orcid":false,"given":"Sofia Azeredo","family":"Pereira","sequence":"additional","affiliation":[{"name":"iNOVA4Health, LS4Future, NOVA Medical School|Faculdade de Ci\u00eancias M\u00e9dicas (NMS|FCM), Universidade Nova de Lisboa, 1150-082 Lisboa, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7395-5700","authenticated-orcid":false,"given":"Paula","family":"Guedes de Pinho","sequence":"additional","affiliation":[{"name":"Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"},{"name":"UCIBIO\u2014Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]},{"given":"F\u00e9lix","family":"Carvalho","sequence":"additional","affiliation":[{"name":"Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"},{"name":"UCIBIO\u2014Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5078-980X","authenticated-orcid":false,"given":"Susana Isabel","family":"S\u00e1","sequence":"additional","affiliation":[{"name":"Unit of Anatomy, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"},{"name":"Center for Health Technology and Services Research (CINTESIS), Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6424-0976","authenticated-orcid":false,"given":"Eduarda","family":"Fernandes","sequence":"additional","affiliation":[{"name":"LAQV-REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0471-2756","authenticated-orcid":false,"given":"Vera Marisa","family":"Costa","sequence":"additional","affiliation":[{"name":"Associate Laboratory i4HB, Institute for Health and Bioeconomy, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"},{"name":"UCIBIO\u2014Applied Molecular Biosciences Unit, Laboratory of Toxicology, Department of Biological Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00204-021-03171-4","article-title":"Four decades of chemotherapy-induced cognitive dysfunction: Comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events","volume":"96","author":"Ferreira","year":"2022","journal-title":"Arch. Toxicol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/annonc\/mdf241","article-title":"Late effects of adjuvant chemotherapy on cognitive function: A follow-up study in breast cancer patients","volume":"13","author":"Schagen","year":"2002","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1200\/JCO.2001.19.3.742","article-title":"Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients with Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma","volume":"19","author":"Soussain","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1212\/WNL.63.12_suppl_6.S15","article-title":"Mechanism of action of mitoxantrone","volume":"63","author":"Fox","year":"2004","journal-title":"Neurology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/14740338.4.2.219","article-title":"Toxicity of the topoisomerase II inhibitors","volume":"4","author":"Seiter","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_6","unstructured":"Immunex Corporation (2023, June 06). Novantrone (Mitoxantrone Hydrochloride). Drug Approval Package. U.S. Food and Drug Administration Website, Available online: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2000\/21120_Novantrone.cfm."},{"key":"ref_7","unstructured":"Avenda\u00f1o, C., and Men\u00e9ndez, J.C. (2008). Medicinal Chemistry of Anticancer Drugs, Elsevier."},{"key":"ref_8","unstructured":"Chackalamannil, S., Rotella, D., and Ward, S.E. (2017). Comprehensive Medicinal Chemistry III, Elsevier."},{"key":"ref_9","unstructured":"Maghzi, A.-H., Borazanci, A., McGee, J., Steven Alexander, J., Gonzalez-Toledo, E., and Minagar, A. (2011). Neuroinflammation, Elsevier."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/sj.leu.2400623","article-title":"A randomized trial of high- vs. standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia","volume":"11","author":"Feldman","year":"1997","journal-title":"Leukemia"},{"key":"ref_11","first-page":"143","article-title":"Assessment of Real-World Central Nervous System Events in Patients with Advanced Prostate Cancer Using Abiraterone Acetate, Bicalutamide, Enzalutamide, or Chemotherapy","volume":"10","author":"Pilon","year":"2017","journal-title":"Am. Health Drug Benefits"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.critrevonc.2008.07.015","article-title":"Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemia","volume":"69","author":"Alibhai","year":"2009","journal-title":"Crit. Rev. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11060-005-3030-x","article-title":"Systemic Temozolomide Combined with Loco-regional Mitoxantrone in Treating Recurrent Glioblastoma","volume":"75","author":"Boiardi","year":"2005","journal-title":"J. Neuro-Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.2174\/138161211797440186","article-title":"Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up","volume":"17","author":"Agarwal","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/03602538608998294","article-title":"Pharmacokinetics of Mitoxantrone in Man and Laboratory Animals","volume":"17","author":"Batra","year":"1986","journal-title":"Drug Metab. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1093\/brain\/awac019","article-title":"Intrinsic blood\u2013brain barrier dysfunction contributes to multiple sclerosis pathogenesis","volume":"145","author":"Nishihara","year":"2022","journal-title":"Brain"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1021\/tx400130v","article-title":"The Heart as a Target for Xenobiotic Toxicity: The Cardiac Susceptibility to Oxidative Stress","volume":"26","author":"Costa","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jneuroim.2013.11.005","article-title":"Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment","volume":"266","author":"Gajewska","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Reis-Mendes, A., Dores-Sousa, J.L., Padr\u00e3o, A.I., Duarte-Ara\u00fajo, M., Duarte, J.A., Seabra, V., Gon\u00e7alves-Monteiro, S., Remi\u00e3o, F., Carvalho, F., and Sousa, E. (2021). Inflammation as a Possible Trigger for Mitoxantrone-Induced Cardiotoxicity: An In Vivo Study in Adult and Infant Mice. Pharmaceuticals, 14.","DOI":"10.3390\/ph14060510"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s00204-022-03261-x","article-title":"Chemobrain: Mitoxantrone-induced oxidative stress, apoptotic and autophagic neuronal death in adult CD-1 mice","volume":"96","author":"Ferreira","year":"2022","journal-title":"Arch. Toxicol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/ajco.13484","article-title":"Measurement, outcomes and interventions of cognitive function after breast cancer treatment: A narrative review","volume":"17","author":"Jia","year":"2021","journal-title":"Asia-Pac. J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0301-0082(99)00060-X","article-title":"Metabolism and functions of glutathione in brain","volume":"62","author":"Dringen","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s00204-013-1040-6","article-title":"The metabolic profile of mitoxantrone and its relation with mitoxantrone-induced cardiotoxicity","volume":"87","author":"Rossato","year":"2013","journal-title":"Arch. Toxicol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejps.2017.05.010","article-title":"Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanisms","volume":"105","author":"Grilo","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_25","first-page":"8","article-title":"Glutathione!","volume":"13","author":"Pizzorno","year":"2014","journal-title":"Integr. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/jf501338z","article-title":"Increase in the Protein-Bound Form of Glutathione in Human Blood after the Oral Administration of Glutathione","volume":"62","author":"Park","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0006-2952(02)01173-5","article-title":"Glutathione catabolism as a signaling mechanism","volume":"64","author":"Paolicchi","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"ref_28","first-page":"286","article-title":"Serum \u03b3-glutamyltransferase as Oxidative Stress Marker in Pre-and Postmenopausal Iraqi Women","volume":"25","author":"Zillo","year":"2010","journal-title":"Oman Med. J."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Iskusnykh, I.Y., Zakharova, A.A., and Pathak, D. (2022). Glutathione in Brain Disorders and Aging. Molecules, 27.","DOI":"10.3390\/molecules27010324"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/j.bbagen.2012.09.008","article-title":"Glutathione synthesis","volume":"1830","author":"Lu","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fneur.2017.00176","article-title":"Neuroprotective Roles of l-Cysteine in Attenuating Early Brain Injury and Improving Synaptic Density via the CBS\/H2S Pathway Following Subarachnoid Hemorrhage in Rats","volume":"8","author":"Li","year":"2017","journal-title":"Front. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10571-012-9867-6","article-title":"Chronic Inflammation Alters Production and Release of Glutathione and Related Thiols in Human U373 Astroglial Cells","volume":"33","author":"Steele","year":"2013","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ara\u00fajo, A.M., Carvalho, F., de Pinho, P.G., and Carvalho, M. (2021). Toxicometabolomics: Small Molecules to Answer Big Toxicological Questions. Metabolites, 11.","DOI":"10.3390\/metabo11100692"},{"key":"ref_34","unstructured":"Clarkson, M.R., Magee, C.N., and Brenner, B.M. (2011). Pocket Companion to Brenner and Rector\u2019s the Kidney, W.B. Saunders. [8th ed.]."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00705812","article-title":"The cerebral lesions in a patient with generalized glutathione deficiency and pyroglutamic aciduria (5-oxoprolinuria)","volume":"52","author":"Skullerud","year":"1980","journal-title":"Acta Neuropathol."},{"key":"ref_36","unstructured":"Brady, S.T., Siegel, G.J., Albers, R.W., and Price, D.L. (2012). Basic Neurochemistry, Academic Press. [8th ed.]."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35044114","article-title":"A ubiquitin-like system mediates protein lipidation","volume":"408","author":"Ichimura","year":"2000","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1096\/fj.02-1167fje","article-title":"Impaired adrenal catecholamine system function in mice with deficiency of the ascorbic acid transporter (SVCT2)","volume":"17","author":"Bornstein","year":"2003","journal-title":"FASEB J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3164\/jcbn.20-181","article-title":"Ascorbate is a multifunctional micronutrient whose synthesis is lacking in primates","volume":"69","author":"Fujii","year":"2021","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.2042-7158.1975.tb10244.x","article-title":"Cerebral monoamine metabolism in guinea-pigs with ascorbic acid deficiency","volume":"27","author":"Saner","year":"1975","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.freeradbiomed.2008.12.018","article-title":"Vitamin C function in the brain: Vital role of the ascorbate transporter SVCT2","volume":"46","author":"Harrison","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(96)00382-4","article-title":"Inhibition of free radical production or free radical scavenging protects from the excitotoxic cell death mediated by glutamate in cultures of cerebellar granule neurons","volume":"728","author":"Ciani","year":"1996","journal-title":"Brain Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Vesga-Jim\u00e9nez, D.J., Martin, C., Barreto, G.E., Aristiz\u00e1bal-Pach\u00f3n, A.F., Pinz\u00f3n, A., and Gonz\u00e1lez, J. (2022). Fatty Acids: An Insight into the Pathogenesis of Neurodegenerative Diseases and Therapeutic Potential. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23052577"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e44702","DOI":"10.7554\/eLife.44702","article-title":"CNS myelination and remyelination depend on fatty acid synthesis by oligodendrocytes","volume":"8","author":"Dimas","year":"2019","journal-title":"eLife"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1007\/s12035-022-02756-z","article-title":"Palmitic Acid and Oleic Acid Differently Modulate TLR2-Mediated Inflammatory Responses in Microglia and Macrophages","volume":"59","author":"Howe","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ydbio.2018.12.009","article-title":"Glycerophospholipids\u2014Emerging players in neuronal dendrite branching and outgrowth","volume":"451","author":"Ziegler","year":"2019","journal-title":"Dev. Biol."},{"key":"ref_47","first-page":"1050","article-title":"Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats","volume":"1761","author":"DeMar","year":"2006","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Mol. Cell Biol. Lipids"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/jcbfm.2013.128","article-title":"Why does Brain Metabolism not Favor Burning of Fatty Acids to Provide Energy?\u2014Reflections on Disadvantages of the Use of Free Fatty Acids as Fuel for Brain","volume":"33","author":"Reiser","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Szablewski, L. (2021). Brain Glucose Transporters: Role in Pathogenesis and Potential Targets for the Treatment of Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22158142"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1471-4159.2001.00598.x","article-title":"Neuronal differentiation is triggered by oleic acid synthesized and released by astrocytes","volume":"79","author":"Tabernero","year":"2001","journal-title":"J. Neurochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e2023784119","DOI":"10.1073\/pnas.2023784119","article-title":"Oleic acid is an endogenous ligand of TLX\/NR2E1 that triggers hippocampal neurogenesis","volume":"119","author":"Kandel","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.phrs.2016.04.015","article-title":"Where\u2019s my entourage? The curious case of 2-oleoylglycerol, 2-linolenoylglycerol, and 2-palmitoylglycerol","volume":"110","author":"Murataeva","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_53","unstructured":"Szabo, B., and Schlicker, E. (2005). Handbook of Experimental Pharmacology, Springer."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s13238-014-0131-3","article-title":"Cholesterol metabolism and homeostasis in the brain","volume":"6","author":"Zhang","year":"2015","journal-title":"Protein Cell"},{"key":"ref_55","first-page":"624","article-title":"The laboratory rat: Relating its age with human\u2019s","volume":"4","author":"Sengupta","year":"2013","journal-title":"Int. J. Prev. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"117242","DOI":"10.1016\/j.lfs.2019.117242","article-title":"Correlation between mouse age and human age in anti-tumor research: Significance and method establishment","volume":"242","author":"Wang","year":"2020","journal-title":"Life Sci."},{"key":"ref_57","first-page":"198","article-title":"Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis","volume":"78","author":"Paul","year":"2007","journal-title":"Br. Med. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/ijc.2910590418","article-title":"Circadian changes in mitoxantrone toxicity in mice: Relationship with plasma pharmacokinetics","volume":"59","author":"Tampellini","year":"1994","journal-title":"Int. J. Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"152852","DOI":"10.1016\/j.tox.2021.152852","article-title":"Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine model","volume":"459","author":"Brandao","year":"2021","journal-title":"Toxicology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jchromb.2007.02.024","article-title":"Simultaneous determination of total homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma by high-performance liquid chromatography: Application to studies of oxidative stress","volume":"852","author":"Nolin","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00204-020-02949-2","article-title":"In vivo toxicometabolomics reveals multi-organ and urine metabolic changes in mice upon acute exposure to human-relevant doses of 3,4-methylenedioxypyrovalerone (MDPV)","volume":"95","author":"Carvalho","year":"2021","journal-title":"Arch. Toxicol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Pluskal, T., Castillo, S., Villar-Briones, A., and Ore\u0161i\u010d, M. (2010). MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinform., 11.","DOI":"10.1186\/1471-2105-11-395"},{"key":"ref_63","first-page":"92","article-title":"Multivariate analysis in metabolomics","volume":"1","author":"Worley","year":"2013","journal-title":"Curr. Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ijnurstu.2012.01.015","article-title":"Effect size estimation: Methods and examples","volume":"49","author":"Berben","year":"2012","journal-title":"Int. J. Nurs. Stud."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/17\/13126\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:40:57Z","timestamp":1760128857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/17\/13126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":65,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["ijms241713126"],"URL":"https:\/\/doi.org\/10.3390\/ijms241713126","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,23]]}}}